NGS Group
2.31 SEK
+4.05 %
Less than 1K followers
NGS
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for NGS Group
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 548.6 | 432.2 | 495.9 | 571.2 | 499.6 | 350.4 | 283.2 |
| growth-% | -21.2 % | 14.7 % | 15.2 % | -12.5 % | -29.9 % | -19.2 % | |
| EBITDA | 23.6 | 16.7 | 23.4 | 12.1 | -14.5 | -17.3 | 6.7 |
| EBIT | 19.0 | 11.5 | 18.4 | 6.9 | -127.0 | -72.6 | -27.9 |
| Profit before taxes | 17.6 | 10.2 | 16.8 | 4.9 | -130.5 | -76.2 | -30.8 |
| Net income | 13.7 | 8.1 | 13.2 | 3.7 | -125.8 | -71.9 | -30.8 |
| EPS | 1.32 | 0.78 | 1.27 | 0.36 | -12.11 | -3.68 | -1.24 |
| Dividend | 0.87 | 0.00 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 65.9 % | 0.0 % | 34.2 % | 0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 4.3 % | 3.9 % | 4.7 % | 2.1 % | -2.9 % | -4.9 % | 2.4 % |
| EBIT-% | 3.5 % | 2.7 % | 3.7 % | 1.2 % | -25.4 % | -20.7 % | -9.9 % |
| ROE | 6.2 % | 3.5 % | 5.4 % | 1.5 % | -107.7 % | -78.0 % | -50.9 % |
| ROI | 4.2 % | 2.6 % | 3.9 % | 1.0 % | -55.4 % | -45.8 % | -26.6 % |